Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020;7(3):140-141.
doi: 10.14283/jpad.2020.27.

Editorial: A Is for Amyloid

D J Selkoe  1
Affiliations
Editorial

Editorial: A Is for Amyloid

D J Selkoe. J Prev Alzheimers Dis. 2020.
No abstract available

PubMed Disclaimer

References

    1. P.S. Aisen, J. Cummings, R. Doody, L. Kramer, S. Salloway, D.J. Selkoe, J. Sims, R.A. Sperling, B. Vellas and the EU/US CTAD 2019 Task Force*. The Future of Anti-Amyloid Trials. The Journal of Prevention of Alzheimer’s Disease - JPAD. March 2020. - PubMed
    1. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med. 2008;14(8):837–42. doi: 10.1038/nm1782. - DOI - PMC - PubMed
    1. Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, Brody DL. Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls. Ann Neurol. 2013;73(1):104–19. doi: 10.1002/ana.23748. - DOI - PMC - PubMed
    1. Jin M, O’Nuallain B, Hong W, Boyd J, Lagomarsino VN, O’Malley TT, Liu W, Vanderburg CR, Frosch MP, Young-Pearse T, Selkoe DJ, Walsh DM. An in vitro paradigm to assess potential anti-aβ antibodies for Alzheimer’s disease. Nat Commun. 2018;9(1):2676. doi: 10.1038/s41467-018-05068-w. - DOI - PMC - PubMed

Publication types

MeSH terms